Blueprint Medicines (NASDAQ:BPMC) Given New $83.00 Price Target at The Goldman Sachs Group themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Shares of Blueprint Medicines Co. (NASDAQ:BPMC – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the fifteen research firms that are covering the firm, Marketbeat reports. Two analysts have rated the stock with a sell recommendation, three have given a hold recommendation, nine have issued a buy recommendation and one […]
Nisa Investment Advisors LLC grew its stake in Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by 158.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,605 shares of the biotechnology company’s stock after buying an additional 983 shares during the quarter. […]
Wells Fargo & Company upgraded shares of Blueprint Medicines (NASDAQ:BPMC – Free Report) from an equal weight rating to an overweight rating in a research note published on Monday morning, Marketbeat.com reports. They currently have $82.00 price objective on the biotechnology company’s stock, up from their previous price objective of $55.00. A number of other […]
Blueprint Medicines Co. Expected to Post Q1 2024 Earnings of ($2.24) Per Share (NASDAQ:BPMC) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.